Reduced heart rate variability is related to the number of metabolic syndrome components and manifest diabetes in the sixth Tromso study 2007-2008

Both diabetes mellitus (DM) and the metabolic syndrome (MetS) are associated with autonomic neuropathy, which predisposes to cardiac events and death. Measures of heart rate variability (HRV) can be used to monitor the activity of the autonomic nervous system (ANS), and there are strong indications that HRV can be used to study the progression of ANS-related diabetes complications. This study aims to investigate differences in HRV in healthy, MetS and diabetic populations. Based on 7880 participants from the sixth health survey in Tromso (Tromso 6, 2007-2008), we found a significant negative association between the number of MetS components and HRV as estimated from short-term pulse wave signals (PRV). This decrease in PRV did not appear to be linear, instead it leveled off after the third component, with no significant difference in PRV between the MetS and DM populations. There was a significant negative association between HbA1c and PRV, showing a decrease in PRV occurring already within the normal HbA1c range. The MetS and DM populations are different from healthy controls with respect to PRV, indicating impaired ANS in both conditions. In the future, a study with assessment of PRV measurements in relation to prospective cardiovascular events seems justified.

Automated summary

This study investigates the differences in heart rate variability (HRV) among healthy individuals, individuals with metabolic syndrome (MetS), and individuals with diabetes. The study finds a significant negative association between the number of MetS components and HRV, with the decrease in HRV leveling off after the third component. Additionally, there is a significant negative association between HbA1c and HRV. It suggests that both MetS and diabetes populations have impaired autonomic nervous system function compared to healthy controls.